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disagree on issues as fundamental as the definition 
of a hormone and the precise nature of the hor- 
mone receptor, and are therefore unlikely to pro- 
duce a consensus on receptor classification. By 
analogy with developments in biochemistry which 
led to the establishment of the International En- 
zyme Commission’s classification of enzymes, 
Black argues that an agreed system of receptor 
classification would establish the standards against 
which proposals on any new receptor could be 
judged. The criteria, whenever they are drafted 
and accepted, will inevitably include phar- 
macological, physiological and biochemical 
evidence, a mixture that is foreshadowed by the in- 
terdisciplinary nature of the contributions to this 
volume. 
The classical pharmacology approach related 
drugs and hormones to physiological conse- 
quences. The need now, more than ever in view of 
the proliferation of receptor sub-types, is to 
describe receptor structure and the molecular 
events that follow association of ligand and recep- 
tor. The authors in this volume review in a concise 
and critical way the techniques, experimental 
evidence and theoretical concepts that are beginn- 
ing to provide the basis for a more analytical ap- 
proach to receptor classification. 
Apart from the academic interest in the subject 
that has such an impact on our understanding of 
tissue function, there are major implications for 
the drug designers who aim to produce more selec- 
tive drug action. Smith Kline & French clearly 
recognise this and are to be congratulated for sup- 
porting the conference and the publication of its 
papers. Though the volume is expensive, the 
scholarship it draws on and the manner of its 
presentation make for stimulating reading for any 
biologist with an interest in hormones and 
transmitters. 
Keith Burdett 
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The title of this book is somewhat misleading, 
since only a small proportion of the book deals 
with receptors on tumour cells, at least in the con- 
ventional sense of this term. In the Introduction, 
the editor states “The present book is about the 
phenomenon of recognition. It attempts to 
describe the basic biology of cancer and treatment 
of the disease in terms of the tumour-specific aber- 
ration.. . and the target which this presents to an 
agent of the immune system, for a growth factor or 
to an exogenously supplied drug.” 
Of the ten chapters of the book, seven deal with 
various aspects of tumour immunology. The first 
is a good overview of natural killer cell physiology, 
with special emphasis on recognition structures, 
and activation of target cell lysis. Chapter 2 is ad- 
dressed to macrophage-mediated tumour cell 
destruction, but is concerned mainly with the use 
of liposomes for the efficient delivery of 
macrophage activation factors. Both this, and the 
next chapter, dealing with synergy between in- 
terferons, are essentially phenomenological, with 
almost no discussion of basic cellular mechanisms, 
and none at all of cellular receptors. Chapters 
7-10 deal collectively with tumour antigens, defin- 
ed exclusively by antibodies. Chapter 7 briefly 
reviews the intensive search for tumour-specific 
antigens, which has produced a number of useful 
diagnostic markers, but very few truly tumour- 
specific antigens. Chapter 8 discusses the use of fu- 
sions between tumour and normal cells to look for 
surface proteins involved in malignancy, and con- 
centrates particularly on changes in the glucose 
transport system associated with malignant 
phenotype. Chapter 9 is a brief description of a 
mouse model system for looking at potential im- 
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munotherapy of hepatocellular carcinoma, 
monoclonal antibodies for hepatitis B surface an- 
tigen, while Chapter 10 describes the methodology 
and clinical problems of using anti idiotypes for 
the treatment of B cell lymphomas. 
To complement the immunology, there, are 
general reviews on growth factors and on 
desmosomes, and their role in cell attachment. 
Both deal mainly with the events occurring in nor- 
mal cellular physiology, rather than specifically in 
tumour cells. The chapter on growth factors con- 
tains one of the few detailed sections on receptors 
in the book, though the recent rapid advances in 
this field, particularly at a molecular level, have 
made the discussion incomplete and already 
somewhat out of date. Finally there is a long 
chapter dealing in great detail with the use of the 
human amnion membrane system to study tumour 
cell substrate interactions. 
In general, most chapters concentrate on a 
description of cellular, rather than molecular 
events. Unfortunately, this has resulted in a lot of 
purely descriptive material, unsupported by any 
hypothetical framework. There are also a number 
of surprising omissions, in particular any extensive 
discussion of oncogenic viruses or the mode of at- 
tion of carcinogens, both subjects closely related to 
receptor biology. However, the book does provide 
a useful summary of a number of important fields 
within tumour cell biology, and the bibliographies 
are mostly quite extensive. 
B. Chain 
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At first glance this new volume on human hor- 
mones is set out to a traditional pattern of each 
chapter dealing with one hormone group. 
However, the authors had set themselves the task 
of assembling material for teaching cellular and 
molecular endocrinology and consequently their 
book has some refreshingly new features. Apart 
from two introductory chapters, one on hormones 
generally and the other on steroid hormone 
metabolism, the remaining 17 chapters have the 
same format. The anatomical-morphological rela- 
tionships of the gland or system are outlined, 
followed in order by the chemistry, biochemistry, 
biological and molecular action of the hormone 
and some clinical aspects. Consequently each 
chapter is a fairly comprehensive but readable 
review. 
In addition to the endocrine substances one 
would expect to be included in a treatise on human 
hormones there are interesting reviews on pro- 
staglandins, thymus and pineal hormones and cell 
growth factors. There are also a collection of ap- 
pendices which deal among other matters with 
blood concentrations of hormones. 
By writing the book rather than acting as editors 
of specialist contributions, the authors have pro- 
duced a consistency of style in presentation that 
medical and science undergraduates and 
postgraduate students alike should find attractive. 
The illustrations, particularly the line drawings 
and anatomical ink washes, are excellent. In all but 
five of the chapters the reference citations include 
material published just one year before the book 
itself, so there are opportunities to follow up with 
more detailed studies. 
Inevitably when the remit is so difficult and all- 
embracing there are penalties arising from the for- 
mat chosen to present the information. Students 
wishing, for example, to review current ideas on 
hormone receptor action or the effects of hor- 
mones on gene expression will have to abstract he 
relevant material from each chapter. No author 
can succeed totally, but my feeling is that Norman 
and Litwack will make a good many friends among 
teaching staff for their monumental effort. 
Keith Burdett 
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